Zacks Investment Research on MSN
Pacific Biosciences of California (PACB) stock sinks as market gains: Here's why
In the latest close session, Pacific Biosciences of California (PACB) was down 2.89% at $1.68. The stock fell short of the S&P 500, which registered a gain of 0.79% for the day. Meanwhile, the Dow ...
Pacific Biosciences of California (PACB) shares fell 16% after the company reported Q1 results that included a wider-than-expected revenue miss and weaker profitability metrics. PacBio reported Q1 non ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results